Tepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study Meeting Abstract


Authors: Park, K.; Felip, E.; Veillon, R.; Cortot, A.; Mazieres, J.; Sakai, H.; Reinmuth, N.; Viteri, S.; Chen, Y. M.; Han, J. Y.; Jang, T. W.; Morise, M.; Sakamoto, T.; Tokito, T.; Cho, B. C.; Bruns, R.; Scheele, J.; Straub, J.; Le, X.; Paik, P. K.
Abstract Title: Tepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study
Meeting Title: 2019 ESMO Asia Congress
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 9
Meeting Dates: 2019 Nov 22-24
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-11-01
Start Page: mdz420.001
Language: English
ACCESSION: WOS:000503487700062
PROVIDER: wos
DOI: 10.1093/annonc/mdz420.001
Notes: Meeting Abstract: 62O -- Appears on pages ix22-ix23 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    257 Paik